{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:03:12Z","timestamp":1787918592872,"version":"build-2784847793"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The global burden of chronic health conditions is significant. Medicinal cannabis (MC) is a legalised treatment option for patients with chronic health conditions in some countries. Health-related quality of life (HRQL) is an important patient-reported outcome across all chronic health conditions. We aimed to determine how studies of MC therapy justify, measure, and report HRQL, and assess the current evidence for HRQL following MC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Systematic review searching AMED, Medline, Web of Science, Scopus, Embase, Cinahl, and PsycINFO from Jan 2015 to Apr 2025. Studies using validated HRQL measures pre-, and post-MC treatment for any chronic health condition were included. Screening and data extraction were performed independently by two reviewers. Completeness of HRQL reporting was evaluated. Meta-analyses for short-term (2-weeks to 3-months), medium-term (&gt;\u20093 to &lt;\u200912-months), and long-term (\u2265\u200912-months) HRQL outcomes were conducted, with Risk of Bias (RoB) assessed in randomised control trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 16,674 retrieved citations, 64 studies were retained for analysis:12 RCTs; 38 cohort studies; 13 case series; 1 non-randomised experimental study. Thirty-nine studies (61%) provided justification for assessing HRQL and five (8%) provided HRQL definitions. Studies used generic (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200952, 81%) or condition-specific (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912, 19%) HRQL measures, with EQ-5D-5L most commonly used. Meta-analyses: RCTs showed small short-term HRQL improvements (Cohen\u2019s d\u2009=\u20090.30,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03), with some concerns or low RoB. For observational studies, HRQL improved in all follow-up periods (d\u2009=\u20090.43 to 0.74; all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). HRQL improvement varied between, and within, different health conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This systematic review and meta-analyses of studies published between 2015 and 2025 found that few studies provided HRQL definitions, and a third of studies did not explain why they measured HRQL. To ensure appropriate measures are used for this important treatment outcome, future studies should define HRQL and justify the HRQL assessment in the context of research objectives. Overall, improvements in HRQL were observed across studies of patients using MC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11136-026-04170-7","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T09:17:57Z","timestamp":1769937477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015\u20132025"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-1049","authenticated-orcid":false,"given":"Margaret-Ann","family":"Tait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8648-5570","authenticated-orcid":false,"given":"Louise","family":"Acret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-0620","authenticated-orcid":false,"given":"Daniel S. J.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5013-8361","authenticated-orcid":false,"given":"Rachel","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-1734","authenticated-orcid":false,"given":"Kate","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4637-4572","authenticated-orcid":false,"given":"Claudia","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"10100","key":"4170_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., Aboyans, V., Abu-Raddad, L. J., Ackerman, I. N., Adamu, A. A., Adetokunboh, O., Afarideh, M., Afshin, A., Agarwal, S. K., Aggarwal, R., et al. (2017). Global, regional, and National incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: A systematic analysis for the global burden of disease study 2016. The Lancet, 390(10100), 1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2","journal-title":"The Lancet"},{"key":"4170_CR2","doi-asserted-by":"crossref","unstructured":"Robson, P. (2005). Human studies of cannabinoids and medicinal cannabis. In R. G. Pertwee (Ed.), Cannabinoids. Handbook of experimental Pharmacology (Vol. 168, pp. 719\u2013756). Springer.","DOI":"10.1007\/3-540-26573-2_25"},{"key":"4170_CR3","unstructured":"Social Council of the United Nations. (1972). Single convention on narcotic drugs, 1961. https:\/\/www.unodc.org\/pdf\/convention_1961_en.pdf"},{"key":"4170_CR4","doi-asserted-by":"publisher","first-page":"747229","DOI":"10.3389\/fnins.2021.747229","volume":"15","author":"RA de Melo Reis","year":"2021","unstructured":"de Melo Reis, R. A., Isaac, A. R., Freitas, H. R., de Almeida, M. M., Schuck, P. F., Ferreira, G. C., Andrade-da-Costa, B., & Trevenzoli, I. H. (2021). Quality of life and a surveillant endocannabinoid system. Frontiers in Neuroscience, 15, 747229. https:\/\/doi.org\/10.3389\/fnins.2021.747229","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"4170_CR5","first-page":"178","volume":"37","author":"CS Gautam","year":"2017","unstructured":"Gautam, C. S., Pandey, A., Tahlan, A., & Gautam, S. S. (2017). Opioid use in palliative care\/chronic pain: Ethical & legal perspectives in India. Biomedicine, 37(2), 178\u2013182.","journal-title":"[Review] Biomedicine (India)"},{"issue":"12","key":"4170_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/AJP.0000000000000364","volume":"32","author":"S Haroutounian","year":"2016","unstructured":"Haroutounian, S., Ratz, Y., Ginosar, Y., Furmanov, K., Saifi, F., Meidan, R., & Davidson, E. (2016). The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: A prospective open-label study. The Clinical Journal of Pain, 32(12), 1036\u20131043. https:\/\/doi.org\/10.1097\/AJP.0000000000000364","journal-title":"The Clinical Journal of Pain"},{"key":"4170_CR7","unstructured":"Therapeutic Goods Administration. (2016). Final decisions and reasons for decisions by a delegate of the secretary to the department of health. https:\/\/www.tga.gov.au\/sites\/default\/files\/scheduling-delegates-final-decisions-cannabis-and-tetrahydrocannabinols-march-2016_0.pdf. Accessed 25 May 2025."},{"issue":"3","key":"4170_CR8","doi-asserted-by":"publisher","first-page":"e0271079","DOI":"10.1371\/journal.pone.0271079","volume":"18","author":"M Shim","year":"2023","unstructured":"Shim, M., Nguyen, H., & Grootendorst, P. (2023). Lessons from 20 years of medical cannabis use in Canada. Plos One, 18(3), e0271079. https:\/\/doi.org\/10.1371\/journal.pone.0271079","journal-title":"Plos One"},{"key":"4170_CR9","unstructured":"Dysa, Y. (2024). Ukraine legalises cannabis for medical use. Reuters."},{"key":"4170_CR10","unstructured":"Food and Drug Administration. (2009). Patient reported outcome measures: Use in medical product development to support labelling claims. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims"},{"issue":"5","key":"4170_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3322\/ca.57.5.278","volume":"57","author":"J Lipscomb","year":"2007","unstructured":"Lipscomb, J., Gotay, C. C., & Snyder, C. F. (2007). Patient-reported outcomes in cancer: A review of recent research and policy initiatives. CA: A Cancer Journal for Clinicians, 57(5), 278\u2013300. https:\/\/doi.org\/10.3322\/ca.57.5.278","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"4170_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1200\/JCO.1994.12.3.608","volume":"12","author":"D Osoba","year":"1994","unstructured":"Osoba, D. (1994). Lessons learned from measuring health-related quality of life in oncology. Journal of Clinical Oncology, 12(3), 608\u2013616. https:\/\/doi.org\/10.1200\/JCO.1994.12.3.608","journal-title":"Journal of Clinical Oncology"},{"key":"4170_CR13","first-page":"314","volume-title":"Health status andhealth policy: Quality of life in health care evaluation andresource allocation","author":"DL Patrick","year":"1993","unstructured":"Patrick, D. L., & Erickson, P. (1993). Health status and health policy: Quality of life in health care evaluation and resource allocation (p. 314). Oxford University Press."},{"issue":"8","key":"4170_CR14","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s11136-021-02826-0","volume":"30","author":"DSJ Costa","year":"2021","unstructured":"Costa, D. S. J., Mercieca-Bebber, R., Rutherford, C., Tait, M. A., & King, M. T. (2021). How is quality of life defined and assessed in published research? Quality of Life Research, 30(8), 2109\u20132121. https:\/\/doi.org\/10.1007\/s11136-021-02826-0","journal-title":"Quality of Life Research"},{"key":"4170_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2016.12.030","volume":"174","author":"M Goldenberg","year":"2017","unstructured":"Goldenberg, M., Reid, M. W., IsHak, W. W., & Danovitch, I. (2017). The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug and Alcohol Dependence, 174, 80\u201390. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.12.030","journal-title":"Drug and Alcohol Dependence"},{"issue":"24","key":"4170_CR16","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., & Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. Jama, 313(24), 2456\u20132473. https:\/\/doi.org\/10.1001\/jama.2015.6358","journal-title":"Jama"},{"key":"4170_CR17","unstructured":"Health-related quality of life in patients accessing medicinal cannabis for symptom management: Systematic review of primary research since 2015. (2024). PROSPERO. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42022306778"},{"key":"4170_CR18","doi-asserted-by":"crossref","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S. (2021). The Prisma 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.","DOI":"10.1136\/bmj.n71"},{"key":"4170_CR19","doi-asserted-by":"crossref","unstructured":"Furlan, A. D., Pennick, V., Bombardier, C., & van Tulder, M. & from the Editorial Board of the Cochrane Back Review Group. (2009). 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine, 34(18), 1929\u20131941.","DOI":"10.1097\/BRS.0b013e3181b1c99f"},{"key":"4170_CR20","doi-asserted-by":"crossref","unstructured":"Casey, M. B., Smart, K. M., Segurado, R., & Doody, C. (2020). Multidisciplinary-based rehabilitation (MBR) compared with active physical interventions for pain and disability in adults with chronic pain: A systematic review and meta-analysis. The Clinical Journal of Pain, 36(11), 874\u2013886.","DOI":"10.1097\/AJP.0000000000000871"},{"key":"4170_CR21","doi-asserted-by":"publisher","first-page":"e070730","DOI":"10.1136\/bmj-2022-070730","volume":"381","author":"C Liu","year":"2023","unstructured":"Liu, C., Ferreira, G. E., Shaheed, A., Chen, C., Harris, Q., Bailey, I. A., Peul, C. S., Koes, W. C., B., & Lin, C. W. C. (2023). Surgical versus non-surgical treatment for sciatica: Systematic review and meta-analysis of randomised controlled trials. Bmj, 381, e070730. https:\/\/doi.org\/10.1136\/bmj-2022-070730","journal-title":"Bmj"},{"key":"4170_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12\u201319. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.004","journal-title":"European Journal of Internal Medicine"},{"key":"4170_CR23","unstructured":"Veritas Health Innovation. (2025). Covidence systematic review software [computer software]. Melbourne, Australia. Available at http:\/\/www.covidence.org\/"},{"issue":"4","key":"4170_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm, E., Altman, D., Egger, M., Pocock, S., G\u00f8tzsche, P., Vandenbroucke, J., & STROBE Initiative. (2008). The strengthening the reporting of observational studies in epidemiology (strobe)statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology, 61(4), 344\u2013349.","journal-title":"Journal of Clinical Epidemiology"},{"key":"4170_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1477-7525-11-184","volume":"11","author":"M Calvert","year":"2013","unstructured":"Calvert, M., Brundage, M., Jacobsen, P. B., Sch\u00fcnemann, H. J., & Efficace, F. (2013). The consort patient-reported outcome (pro) extension: Implications for clinical trials and practice. Health and Quality of Life Outcomes, 11, 184. https:\/\/doi.org\/10.1186\/1477-7525-11-184","journal-title":"Health and Quality of Life Outcomes"},{"key":"4170_CR26","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"J Sterne","year":"2019","unstructured":"Sterne, J., Savovi\u0107, J., Page, M., Elbers, R., Blencowe, N., Boutron, I., Cates, C., Cheng, H. Y., Corbett, M., Eldridge, S., Hern\u00e1n, M., Hopewell, S., Hr\u00f3bjartsson, A., Junqueira, D., J\u00fcni, P., Kirkham, J., Lasserson, T., Li, T., McAleenan, A., et al. (2019). Rob 2: A revised tool for assessing risk of bias in randomised trials. Bmj, 366, l4898.","journal-title":"Bmj"},{"key":"4170_CR27","doi-asserted-by":"publisher","unstructured":"McGrath, S., Zhao, X., & Steele, R.. (2023). Estmeansd: Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. https:\/\/doi.org\/10.32614\/CRAN.package.estmeansd","DOI":"10.32614\/CRAN.package.estmeansd"},{"key":"4170_CR28","unstructured":"Balk, E. M., Earley, A., Patel, K., Trikalinos, T. A., & Dahabreh, I., J (2012). Empirical assessment of within-arm correlation imputation in trials of continuous outcomes. Methods research report (prepared by the tufts evidence-based practice center under contract no 290-2007-10055-i) Ahrq publication no 12(13)-ehc141-ef. Agency for Healthcare Research and Quality."},{"key":"4170_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-5-54","volume":"5","author":"SS Farivar","year":"2007","unstructured":"Farivar, S. S., Cunningham, W. E., & Hays, R. D. (2007). Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V. 1. Health and Quality of Life Outcomes, 5, 54. https:\/\/doi.org\/10.1186\/1477-7525-5-54","journal-title":"Health and Quality of Life Outcomes"},{"key":"4170_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70024","author":"M Dickinson","year":"2025","unstructured":"Dickinson, M., Erridge, S., Warner-Levy, J., Clarke, E., McLachlan, K., Coomber, R., Holden, W., Rucker, J. J., Platt, M. W., & Sodergren, M. H. (2025). UK medical cannabis registry: An analysis of outcomes of medical cannabis therapy for hypermobility-associated chronic pain. ACR Open Rheumatology. https:\/\/doi.org\/10.1002\/acr2.70024. e70024.","journal-title":"ACR Open Rheumatology"},{"key":"4170_CR31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2147\/JPR.S192174","volume":"12","author":"MA Ueberall","year":"2019","unstructured":"Ueberall, M. A., Essner, U., & Mueller-Schwefe, G. H. H. (2019). Effectiveness and tolerability of thc:cbd oromucosal spray as add-on measure in patients with severe chronic pain: Analysis of 12-week open-label real-world data provided by the German pain e-registry. J Pain Res, 12, 1577\u20131604. https:\/\/doi.org\/10.2147\/JPR.S192174","journal-title":"J Pain Res"},{"issue":"12","key":"4170_CR32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcph.1961","volume":"61","author":"M Kawka","year":"2021","unstructured":"Kawka, M., Erridge, S., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Platt, M. W., Rucker, J. J., & Sodergren, M. H. (2021). Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based Sublingual oils in the United Kingdom: Analysis from the UK medical cannabis registry. Journal of Clinical Pharmacology, 61(12), 1545\u20131554. https:\/\/doi.org\/10.1002\/jcph.1961","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"4170_CR33","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1111\/papr.13438","volume":"25","author":"I Datta","year":"2025","unstructured":"Datta, I., Erridge, S., Holvey, C., Coomber, R., Guru, R., Holden, W., Darweish Medniuk, A., Sajad, M., Searle, R., Usmani, A., Varma, S., Rucker, J. J., Platt, M., & Sodergren, M. H. (2025). UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment. Pain Practice, 25(1), e13438. https:\/\/doi.org\/10.1111\/papr.13438","journal-title":"Pain Practice"},{"issue":"3","key":"4170_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/14737175.2023.2181696","volume":"23","author":"L Bapir","year":"2023","unstructured":"Bapir, L., Erridge, S., Nicholas, M., Pillai, M., Dalavaye, N., Holvey, C., Coomber, R., Hoare, J., Khan, S., Weatherall, M. W., Rucker, J. J., Platt, M., & Sodergren, M. H. (2023). Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study. Expert Review of Neurotherapeutics, 23(3), 281\u2013295. https:\/\/doi.org\/10.1080\/14737175.2023.2181696","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"4","key":"4170_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/14737175.2023.2195551","volume":"23","author":"J Tait","year":"2023","unstructured":"Tait, J., Erridge, S., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Hoare, J., Khan, S., Weatherall, M., Rucker, J. J., Platt, M., & Sodergren, M. H. (2023). Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK medical cannabis registry. Expert Review of Neurotherapeutics, 23(4), 413\u2013423. https:\/\/doi.org\/10.1080\/14737175.2023.2195551","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"12","key":"4170_CR36","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","volume":"16","author":"MA Ware","year":"2015","unstructured":"Ware, M. A., Wang, T., Shapiro, S., & Collet, J. P. (2015). Cannabis for the management of pain: Assessment of safety study (compass). Journal of Pain, 16(12), 1233\u20131242. https:\/\/doi.org\/10.1016\/j.jpain.2015.07.014","journal-title":"Journal of Pain"},{"issue":"11","key":"4170_CR37","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/PM\/PNAA163","volume":"21","author":"R Safakish","year":"2020","unstructured":"Safakish, R., Ko, G., Salimpour, V., Hendin, B., Sohanpal, I., Loheswaran, G., & Yoon, S. Y. R. (2020). Medical cannabis for the management of pain and quality of life in chronic pain patients: A prospective observational study. Pain Medicine, 21(11), 3073\u20133086. https:\/\/doi.org\/10.1093\/PM\/PNAA163","journal-title":"Pain Medicine (Malden, Mass.)"},{"key":"4170_CR38","doi-asserted-by":"publisher","DOI":"10.1159\/000517857","author":"AM Peterson","year":"2021","unstructured":"Peterson, A. M., Le, C., & Dautrich, T. (2021). Measuring the change in health-related quality of life in patients using marijuana for pain relief. Medical Cannabis and Cannabinoids. https:\/\/doi.org\/10.1159\/000517857","journal-title":"Medical Cannabis andCannabinoids"},{"issue":"2","key":"4170_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1037\/pha0000435","volume":"29","author":"SA Gruber","year":"2021","unstructured":"Gruber, S. A., Smith, R. T., Dahlgren, M. K., Lambros, A. M., & Sagar, K. A. (2021). No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms. Experimental and Clinical Psychopharmacology, 29(2), 147\u2013156. https:\/\/doi.org\/10.1037\/pha0000435","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1","key":"4170_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/00325481.2019.1685298","volume":"132","author":"A Capano","year":"2020","unstructured":"Capano, A., Weaver, R., & Burkman, E. (2020). Evaluation of the effects of Cbd hemp extract on opioid use and quality of life indicators in chronic pain patients: A prospective cohort study. Postgraduate Medicine, 132(1), 56\u201361. https:\/\/doi.org\/10.1080\/00325481.2019.1685298","journal-title":"Postgraduate Medicine"},{"key":"4170_CR41","doi-asserted-by":"publisher","first-page":"105665","DOI":"10.1016\/j.msard.2024.105665","volume":"87","author":"M Murphy","year":"2024","unstructured":"Murphy, M., Kaur, V., Bui, H. L., Yang, T., Erridge, S., Holvey, C., Coomber, R., Rucker, J. J., Weatherall, M. W., & Sodergren, M. H. (2024). Clinical outcome analysis of patients with multiple sclerosis - analysis from the UK medical cannabis registry. Multiple Sclerosis and Related Disorders, 87, 105665. https:\/\/doi.org\/10.1016\/j.msard.2024.105665","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"4170_CR42","doi-asserted-by":"publisher","first-page":"11EP","DOI":"10.2217\/nmt-2023-0040","volume":"14","author":"MR Haupts","year":"2024","unstructured":"Haupts, M. R., Essner, U., & Maurer, M. (2024). Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures. Neurodegenerative Disease Management, 14(1), 11\u201320. https:\/\/doi.org\/10.2217\/nmt-2023-0040","journal-title":"Neurodegenerative Disease Management"},{"issue":"5\u20136","key":"4170_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000449413","volume":"76","author":"P Vermersch","year":"2016","unstructured":"Vermersch, P., & Trojano, M. (2016). Tetrahydrocannabinol: Cannabidiol oromucosal spray for multiple sclerosis-related resistant spasticity in daily practice. European Neurology, 76(5\u20136), 216\u2013226. https:\/\/doi.org\/10.1159\/000449413","journal-title":"European Neurology"},{"issue":"14","key":"4170_CR44","first-page":"3127","volume":"20","author":"M Russo","year":"2016","unstructured":"Russo, M., De Luca, R., Torrisi, M., Rifici, C., Sessa, E., Bramanti, P., Naro, A., & Calabro, R. S. (2016). Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study. European Review for Medical and Pharmacological Sciences, 20(14), 3127\u20133133.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"6","key":"4170_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/pm\/pnv080","volume":"17","author":"M Russo","year":"2016","unstructured":"Russo, M., Naro, A., Leo, A., Sessa, E., D\u2019Aleo, G., Bramanti, P., & Calabro, R. S. (2016). Evaluating sativex r in neuropathic pain management: A clinical and neurophysiological assessment in multiple sclerosis. Pain Medicine, 17(6), 1145\u20131154. https:\/\/doi.org\/10.1093\/pm\/pnv080","journal-title":"Pain Medicine"},{"issue":"3","key":"4170_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.35755\/jmedassocthai.2021.03.11919","volume":"104","author":"S Aungsumart","year":"2021","unstructured":"Aungsumart, S., Pongsuthimanus, N., & Apiwattanakul, M. (2021). A pilot study of the government pharmaceutical organization (gpo) cannabis extract for multiple sclerosis (ms) spasticity treatment in Thailand. Journal of the Medical Association of Thailand, 104(3), 460\u2013465. https:\/\/doi.org\/10.35755\/jmedassocthai.2021.03.11919","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"2","key":"4170_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00207454.2018.1481066","volume":"129","author":"J Markova","year":"2019","unstructured":"Markova, J., Essner, U., Akmaz, B., Marinelli, M., Trompke, C., Lentschat, A., & Vila, C. (2019). Sativex as add-on therapy vs. Further optimized first-line antispastics (savant) in resistant multiple sclerosis spasticity: A double-blind, placebo-controlled randomised clinical trial. International Journal of Neuroscience, 129(2), 119\u2013128. https:\/\/doi.org\/10.1080\/00207454.2018.1481066","journal-title":"International Journal of Neuroscience"},{"issue":"5\u20136","key":"4170_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000445943","volume":"75","author":"M Haupts","year":"2016","unstructured":"Haupts, M., Vila, C., Jonas, A., Witte, K., & Alvarez-Ossorio, L. (2016). Influence of previous failed antispasticity therapy on the efficacy and tolerability of thc:cbd oromucosal spray for multiple sclerosis spasticity. European Neurology, 75(5\u20136), 236\u2013243. https:\/\/doi.org\/10.1159\/000445943","journal-title":"European Neurology"},{"key":"4170_CR49","doi-asserted-by":"publisher","unstructured":"Varadpande, M., Erridge, S., Aggarwal, A., Cowley, I., Evans, L., Clarke, E., McLachlan, K., Coomber, R., Rucker, J. J., Platt, M. W., Khan, S., & Sodergren, M. (2025). UK medical cannabis registry: An analysis of clinical outcomes of medicinal cannabis therapy for cancer pain. Journal of Pain & Palliative Care Pharmacotherapy, 39(2): 174\u2013194. https:\/\/doi.org\/10.1080\/15360288.2025.2457101","DOI":"10.1080\/15360288.2025.2457101"},{"issue":"1","key":"4170_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/CAD.0000000000000685","volume":"30","author":"G Bar-Sela","year":"2019","unstructured":"Bar-Sela, G., Tauber, D., Mitnik, I., Sheinman-Yuffe, H., Bishara-Frolova, T., & Aharon-Peretz, J. (2019). Cannabis-related cognitive impairment: A prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study. Anti-Cancer Drugs, 30(1), 91\u201397. https:\/\/doi.org\/10.1097\/CAD.0000000000000685","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"4170_CR51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/10499091221110217","volume":"40","author":"R Nathan","year":"2023","unstructured":"Nathan, R., Mupamombe, C. T., Elibol, J., Case, A. A., Smith, D., Hyland, A., Attwood, K., & Hansen, E. D. (2023). Assessing efficacy and use patterns of medical cannabis for symptom management in elderly cancer patients. The American Journal of Hospice & Palliative Care, 40(4), 368\u2013373. https:\/\/doi.org\/10.1177\/10499091221110217","journal-title":"The American Journal of Hospice & Palliative Care"},{"issue":"7","key":"4170_CR52","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1200\/JCO.22.01632","volume":"41","author":"J Hardy","year":"2023","unstructured":"Hardy, J., Greer, R., Huggett, G., Kearney, A., Gurgenci, T., & Good, P. (2023). Phase Iib randomized, placebo-controlled, dose-escalating, double-blind study of Cannabidiol oil for the relief of symptoms in advanced cancer (medcan1-cbd). Journal of Clinical Oncology, 41(7), 1444\u20131452. https:\/\/doi.org\/10.1200\/JCO.22.01632","journal-title":"Journal of Clinical Oncology"},{"key":"4170_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.649555","author":"J Schloss","year":"2021","unstructured":"Schloss, J., Lacey, J., Sinclair, J., Steel, A., Sughrue, M., Sibbritt, D., & Teo, C. (2021). A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal cannabis in patients with high grade gliomas. Frontiers in Oncology. https:\/\/doi.org\/10.3389\/fonc.2021.649555","journal-title":"Frontiers in Oncology"},{"issue":"6","key":"4170_CR54","doi-asserted-by":"publisher","first-page":"350EP","DOI":"10.1097\/YIC.0000000000000536","volume":"39","author":"A Li","year":"2024","unstructured":"Li, A., Erridge, S., Holvey, C., Coomber, R., Barros, D., Bhoskar, U., Crews, M., Donnelly, L., Imran, M., Korb, L., Mwimba, G., Sachdeva-Mohan, S., Rucker, J. J., & Sodergren, M. H. (2024). Uk medical cannabis registry: A case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients. International Clinical Psychopharmacology, 39(6), 350\u2013360. https:\/\/doi.org\/10.1097\/YIC.0000000000000536","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"4170_CR55","doi-asserted-by":"publisher","first-page":"129EP","DOI":"10.1002\/npr2.12407","volume":"44","author":"M Murphy","year":"2024","unstructured":"Murphy, M., Erridge, S., Holvey, C., Coomber, R., Rucker, J. J., & Sodergren, M. H. (2024). A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance. Neuropsychopharmacology Reports, 44(1), 129\u2013142. https:\/\/doi.org\/10.1002\/npr2.12407","journal-title":"Neuropsychopharmacology Reports"},{"issue":"12","key":"4170_CR56","doi-asserted-by":"publisher","first-page":"1193EP","DOI":"10.1080\/14737175.2024.2423634","volume":"24","author":"J Warner-Levy","year":"2024","unstructured":"Warner-Levy, J., Erridge, S., Clarke, E., McLachlan, K., Coomber, R., Asghar, M., Bexley, K., Bhoskar, U., Crews, M., De Angelis, A., Imran, M., Kamal, F., Korb, L., Mwimba, G., Sachdeva-Mohan, S., Shaya, G., Rucker, J. J., & Sodergren, M. H. (2024). Uk medical cannabis registry: A cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder. Expert Review of Neurotherapeutics, 24(12), 1193\u20131202. https:\/\/doi.org\/10.1080\/14737175.2024.2423634","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"8","key":"4170_CR57","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00213-023-06399-3","volume":"240","author":"R Rifkin-Zybutz","year":"2023","unstructured":"Rifkin-Zybutz, R., Erridge, S., Holvey, C., Coomber, R., Gaffney, J., Lawn, W., Barros, D., Bhoskar, U., Mwimba, G., Praveen, K., Symeon, C., Sachdeva-Mohan, S., Rucker, J. J., & Sodergren, M. H. (2023). Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the united kingdom: A cohort study from the UK medical cannabis registry. Psychopharmacology, 240(8), 1735\u20131745. https:\/\/doi.org\/10.1007\/s00213-023-06399-3","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"4170_CR58","doi-asserted-by":"publisher","first-page":"829EP","DOI":"10.1080\/17474124.2024.2443574","volume":"18","author":"A Gupta","year":"2024","unstructured":"Gupta, A., Erridge, S., Graf, V., Kelada, M., Bapir, L., Jesuraj, N., Warner-Levy, J., Clarke, E., McLachlan, K., Coomber, R., Rucker, J. J., Platt, M. W., & Sodergren, M. H. (2024). Uk medical cannabis registry: An updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology, 18(12), 829\u2013838. https:\/\/doi.org\/10.1080\/17474124.2024.2443574","journal-title":"Expert Review of Gastroenterology and Hepatology"},{"issue":"11","key":"4170_CR59","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","volume":"15","author":"T Naftali","year":"2021","unstructured":"Naftali, T., Bar-Lev Schleider, L., Almog, S., Meiri, D., & Konikoff, F. M. (2021). Oral cbd-rich cannabis induces clinical but not endoscopic response in patients with Crohn\u2019s disease, a randomised controlled trial. Journal of Crohn\u2019s & Colitis, 15(11), 1799\u20131806. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab069","journal-title":"Journal of Crohn\u2019s & Colitis"},{"issue":"2","key":"4170_CR60","doi-asserted-by":"publisher","first-page":"e0246871","DOI":"10.1371\/journal.pone.0246871","volume":"16","author":"T Naftali","year":"2021","unstructured":"Naftali, T., Bar-Lev Schleider, L., Scklerovsky Benjaminov, F., Konikoff, F. M., Matalon, S. T., & Ringel, Y. (2021). Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial. PLoS ONE [Electronic Resource], 16(2), e0246871. https:\/\/doi.org\/10.1371\/journal.pone.0246871","journal-title":"PLoS ONE [Electronic Resource]"},{"issue":"4","key":"4170_CR61","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ibd\/izy002","volume":"24","author":"PM Irving","year":"2018","unstructured":"Irving, P. M., Iqbal, T., Nwokolo, C., Subramanian, S., Bloom, S., Prasad, N., Hart, A., Murray, C., Lindsay, J. O., Taylor, A., Barron, R., & Wright, S. (2018). A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis. Inflammatory Bowel Diseases, 24(4), 714\u2013724. https:\/\/doi.org\/10.1093\/ibd\/izy002","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"4170_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12883-024-03646-8","volume":"24","author":"BA Brett","year":"2024","unstructured":"Brett, B. A., Conroy, M., Doshi, H., Lowe, M. X., Kalcheff-Korn, S., & Jackson, H. (2024). An observational time-series study on the behavioral effects of adjunctive artisanal Cannabidiol use by adults with treatment resistant epilepsies. BMC Neurology, 24(1), 141. https:\/\/doi.org\/10.1186\/s12883-024-03646-8","journal-title":"BMC Neurology"},{"key":"4170_CR63","doi-asserted-by":"publisher","first-page":"110032","DOI":"10.1016\/j.yebeh.2024.110032","volume":"160","author":"J Lamonarca","year":"2024","unstructured":"Lamonarca, J., Mintz, I., Bayarres, L., Kochen, S., & Oddo, S. (2024). Psychiatric comorbidities before and after Cannabidiol treatment in adult patients with drug resistant focal epilepsy. Epilepsy and Behavior, 160, 110032. https:\/\/doi.org\/10.1016\/j.yebeh.2024.110032","journal-title":"Epilepsy and Behavior"},{"key":"4170_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yebeh.2019.03.035","volume":"95","author":"TE Gaston","year":"2019","unstructured":"Gaston, T. E., Szaflarski, M., Hansen, B., Bebin, E. M., & Szaflarski, J. P. (2019). Quality of life in adults enrolled in an open-label study of Cannabidiol (cbd) for treatment-resistant epilepsy. Epilepsy and Behavior, 95, 10\u201317. https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.035","journal-title":"Epilepsy and Behavior"},{"key":"4170_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2024.2414073","author":"S Sridharan","year":"2024","unstructured":"Sridharan, S., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J. J., Platt, M., & Sodergren, M. H. (2024). Comparison of cannabis-based medicinal product formulations for fibromyalgia: A cohort study. Journal of Pain and Palliative Care Pharmacotherapy. https:\/\/doi.org\/10.1080\/15360288.2024.2414073","journal-title":"Journal of Pain and Palliative Care Pharmacotherapy"},{"issue":"2","key":"4170_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/papr.13179","volume":"23","author":"O Hershkovich","year":"2023","unstructured":"Hershkovich, O., Hayun, Y., Oscar, N., Shtein, A., & Lotan, R. (2023). The role of cannabis in treatment-resistant fibromyalgia women. Pain Practice, 23(2), 180\u2013184. https:\/\/doi.org\/10.1111\/papr.13179","journal-title":"Pain Practice : the official Journal of World Institute of Pain"},{"issue":"10","key":"4170_CR67","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/PM\/PNAA303","volume":"21","author":"C Chaves","year":"2020","unstructured":"Chaves, C., Bittencourt, P. C. T., & Pelegrini, A. (2020). Ingestion of a thc-rich cannabis oil in people with fibromyalgia: A randomized, double-blind, placebo-controlled clinical trial. Pain Medicine, 21(10), 2212\u20132218. https:\/\/doi.org\/10.1093\/PM\/PNAA303","journal-title":"Pain Medicine (United States)"},{"key":"4170_CR68","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000556","author":"A Francis","year":"2024","unstructured":"Francis, A., Erridge, S., Holvey, C., Coomber, R., Guru, R., Darweish Medniuk, A., Sajad, M., Searle, R., Usmani, A., Varma, S., Rucker, J., Platt, M., Holden, W., & Sodergren, M. H. (2024). Assessment of clinical outcomes in patients with inflammatory arthritis: Analysis from the UK medical cannabis registry. International Clinical Psychopharmacology. https:\/\/doi.org\/10.1097\/YIC.0000000000000556","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"4170_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/15360288.2024.2340076","volume":"38","author":"A Francis","year":"2024","unstructured":"Francis, A., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J., Platt, M., & Sodergren, M. (2024). Assessment of clinical outcomes in patients with osteoarthritis: Analysis from the UK medical cannabis registry. Journal of Pain and Palliative Care Pharmacotherapy, 38(2), 103\u2013116.","journal-title":"Journal of Pain and Palliative Care Pharmacotherapy"},{"key":"4170_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3410","author":"K Vivek","year":"2024","unstructured":"Vivek, K., Karagozlu, Z., Erridge, S., Holvey, C., Coomber, R., Rucker, J. J., Weatherall, M. W., & Sodergren, M. H. (2024). Uk medical cannabis registry: Assessment of clinical outcomes in patients with insomnia. Brain and Behavior. https:\/\/doi.org\/10.1002\/brb3.3410. e3410.","journal-title":"Brain andBehavior"},{"issue":"3","key":"4170_CR71","doi-asserted-by":"publisher","first-page":"160EP","DOI":"10.35755\/jmedassocthai.2024.3.13952","volume":"107","author":"C Aiewtrakoon","year":"2024","unstructured":"Aiewtrakoon, C. (2024). Efficacy and safety of Cannabidiol oil on chronic insomnia: The first randomized, double-blind, placebo-controlled, crossover, pilot study in Thailand. Journal of the Medical Association of Thailand, 107(3), 160\u2013170. https:\/\/doi.org\/10.35755\/jmedassocthai.2024.3.13952","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"4","key":"4170_CR72","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cpt.2016","volume":"109","author":"L Eibach","year":"2021","unstructured":"Eibach, L., Scheffel, S., Cardebring, M., Lettau, M., Ozgur Celik, M., Morguet, A., Roehle, R., & Stein, C. (2021). Cannabidivarin for HIV-associated neuropathic pain: A randomized, blinded, controlled clinical trial. Clinical Pharmacology & Therapeutics, 109(4), 1055\u20131062. https:\/\/doi.org\/10.1002\/cpt.2016","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"9","key":"4170_CR73","doi-asserted-by":"publisher","first-page":"ofae492","DOI":"10.1093\/ofid\/ofae492","volume":"11","author":"T Barre","year":"2024","unstructured":"Barre, T., Couton, C., Mourad, A., Carrieri, P., Protopopescu, C., Klein, H., De Dieuleveult, B., Hocqueloux, L., Mollet, L., & Prazuck, T. (2024). Limited impact of Cannabidiol on health-related quality of life of people with long-term controlled hiv: A double-blind, randomized, controlled trial. Open Forum Infectious Diseases, 11(9), ofae492. https:\/\/doi.org\/10.1093\/ofid\/ofae492","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"4170_CR74","doi-asserted-by":"publisher","first-page":"149EP","DOI":"10.1159\/000540978","volume":"7","author":"W Sultan","year":"2024","unstructured":"Sultan, W., Madiedo, A., & Moreno-Sanz, G. (2024). Controlled inhalation of tetrahydrocannabinol-predominant cannabis Flos mitigates severity of post-traumatic stress disorder symptoms and improves quality of sleep and general mood in cannabis-experienced UK civilians: A real-world, observational study. Medical Cannabis and Cannabinoids, 7(1), 149\u2013159. https:\/\/doi.org\/10.1159\/000540978","journal-title":"Medical Cannabis and Cannabinoids"},{"issue":"1","key":"4170_CR75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/14737175.2023.2174017","volume":"23","author":"M Nicholas","year":"2023","unstructured":"Nicholas, M., Erridge, S., Bapir, L., Pillai, M., Dalavaye, N., Holvey, C., Coomber, R., Rucker, J. J., Weatherall, M. W., & Sodergren, M. H. (2023). Uk medical cannabis registry: Assessment of clinical outcomes in patients with headache disorders. Expert Review of Neurotherapeutics, 23(1), 85\u201396. https:\/\/doi.org\/10.1080\/14737175.2023.2174017","journal-title":"Expert Review of Neurotherapeutics"},{"key":"4170_CR76","doi-asserted-by":"publisher","DOI":"10.1089\/can.2024.0028","author":"G Dujic","year":"2024","unstructured":"Dujic, G., Kumric, M., Vrdoljak, J., Sutlovic, D., Dujic, Z., & Bozic, J. (2024). Chronic Cannabidiol administration mitigates excessive daytime sleepiness and fatigue in patients with primary hypertension: Insights from a randomized crossover trial. Cannabis and Cannabinoid Research. https:\/\/doi.org\/10.1089\/can.2024.0028","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"5","key":"4170_CR77","doi-asserted-by":"publisher","first-page":"e2312522","DOI":"10.1001\/jamanetworkopen.2023.12522","volume":"6","author":"TR Arkell","year":"2023","unstructured":"Arkell, T. R., Downey, L. A., Hayley, A. C., & Roth, S. (2023). Assessment of medical cannabis and health-related quality of life. JAMA Network Open, 6(5), e2312522. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.12522","journal-title":"JAMA Network Open"},{"issue":"3","key":"4170_CR78","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/can.2021.0145","volume":"8","author":"M Ergisi","year":"2023","unstructured":"Ergisi, M., Erridge, S., Harris, M., Kawka, M., Nimalan, D., Salazar, O., Loupasaki, K., Ali, R., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Beri, S., Hoare, J., Khan, S. A., Weatherall, M. W., Platt, M., Rucker, J. J., & Sodergren, M. H. (2023). An updated analysis of clinical outcome measures across patients from the Uk medical cannabis registry. Cannabis and Cannabinoid Research, 8(3), 557\u2013566. https:\/\/doi.org\/10.1089\/can.2021.0145","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"4170_CR79","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/npr2.12183","volume":"41","author":"S Erridge","year":"2021","unstructured":"Erridge, S., Salazar, O., Kawka, M., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Beri, S., Hoare, J., Khan, S., Weatherall, M. W., Platt, M., Rucker, J. J., & Sodergren, M. H. (2021). An initial analysis of the Uk medical cannabis registry: Outcomes analysis of first 129 patients. Neuropsychopharmacology Reports, 41(3), 362\u2013370. https:\/\/doi.org\/10.1002\/npr2.12183","journal-title":"Neuropsychopharmacology Reports"},{"key":"4170_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320756","author":"MA Tait","year":"2025","unstructured":"Tait, M. A., Costa, D. S. J., Campbell, R., Warne, L. N., Norman, R., Schug, S., & Rutherford, C. (2025). Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in australia: The quest initiative 12-month follow-up observational study. Plos One. https:\/\/doi.org\/10.1371\/journal.pone.0320756. e0320756.","journal-title":"Plos One"},{"issue":"1","key":"4170_CR81","doi-asserted-by":"publisher","first-page":"44EP","DOI":"10.1159\/000536591","volume":"7","author":"MD Kelley","year":"2024","unstructured":"Kelley, M. D., Obaid, M., Miller, E. M., Bowie, M., & Heeter, Z. S. (2024). Observational analysis of the influence of medical marijuana use on quality of life in patients. Medical Cannabis and Cannabinoids, 7(1), 44\u201350. https:\/\/doi.org\/10.1159\/000536591","journal-title":"Medical Cannabis and Cannabinoids"},{"issue":"6","key":"4170_CR82","doi-asserted-by":"publisher","first-page":"521EP","DOI":"10.1007\/s40266-024-01123-y","volume":"41","author":"MT Lynskey","year":"2024","unstructured":"Lynskey, M. T., Thurgur, H., Athanasiou-Fragkouli, A., Schlag, A. K., & Nutt, D. J. (2024). Prescribed medical cannabis use among older individuals: Patient characteristics and improvements in well-being: Findings from t21. Drugs and Aging, 41(6), 521\u2013530. https:\/\/doi.org\/10.1007\/s40266-024-01123-y","journal-title":"Drugs and Aging"},{"issue":"1","key":"4170_CR83","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s42238-024-00245-9","volume":"6","author":"MR Lent","year":"2024","unstructured":"Lent, M. R., McCalmont, T. R., Short, M. M., & Dugosh, K. L. (2024). Changes in health-related quality of life over the first three months of medical marijuana use. Journal of Cannabis Research, 6(1), 36. https:\/\/doi.org\/10.1186\/s42238-024-00245-9","journal-title":"J Cannabis Res"},{"issue":"1","key":"4170_CR84","doi-asserted-by":"publisher","first-page":"125EP","DOI":"10.1159\/000540153","volume":"7","author":"P Stienrut","year":"2024","unstructured":"Stienrut, P., Pongpirul, K., Phutrakool, P., Savigamin, C., Sermsaksasithorn, P., Chanhom, O., Jeamjumrus, P., Pongchaichanon, P., Nootim, P., Soisamrong, M., Chuthaputti, A., Wanaratna, K., & Thaneerat, T. (2024). Medical cannabis prescription practices and quality of life in Thai patients: A nationwide prospective observational cohort study. Medical Cannabis and Cannabinoids, 7(1), 125\u2013137. https:\/\/doi.org\/10.1159\/000540153","journal-title":"Medical Cannabis and Cannabinoids"},{"issue":"9","key":"4170_CR85","doi-asserted-by":"publisher","first-page":"e0290549","DOI":"10.1371\/journal.pone.0290549","volume":"18","author":"MA Tait","year":"2023","unstructured":"Tait, M. A., Costa, D. S. J., Campbell, R., Norman, R., Warne, L. N., Schug, S., & Rutherford, C. (2023). Health-related quality of life in patients accessing medicinal cannabis in Australia: The quest initiative results of a 3-month follow-up observational study. Plos One, 18(9), e0290549. https:\/\/doi.org\/10.1371\/journal.pone.0290549","journal-title":"Plos One"},{"issue":"6","key":"4170_CR86","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1089\/can.2022.0041","volume":"8","author":"A Vigano","year":"2022","unstructured":"Vigano, A., Moride, Y., Hachem, Y., Canac-Marquis, M., Gamaoun, R., Kalaba, M., Martel, M. O., Perez, J., N\u00e9ron, A., Beaulieu, P., Desroches, J., & Ware, M. (2022). The Quebec cannabis registry: Investigating the safety and effectiveness of medical cannabis. Cannabis and Cannabinoid Research, 8(6), 1106\u20131116. https:\/\/doi.org\/10.1089\/can.2022.0041","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"4170_CR87","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/ijpp.12514","volume":"27","author":"B Palmieri","year":"2019","unstructured":"Palmieri, B., Laurino, C., & Vadala, M. (2019). Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (bedrocan). International Journal of Pharmacy Practice, 27(3), 264\u2013270. https:\/\/doi.org\/10.1111\/ijpp.12514","journal-title":"International Journal of Pharmacy Practice"},{"issue":"5","key":"4170_CR88","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12630-020-01903-1","volume":"68","author":"H Meng","year":"2021","unstructured":"Meng, H., Page, M. G., Ajrawat, P., Deshpande, A., Samman, B., Dominicis, M., Ladha, K. S., Fiorellino, J., Huang, A., Kotteeswaran, Y., McClaren-Blades, A., Kotra, L. P., & Clarke, H. (2021). Patient-reported outcomes in those consuming medical cannabis: A prospective longitudinal observational study in chronic pain patients. Canadian Journal of Anesthesia, 68(5), 633\u2013644. https:\/\/doi.org\/10.1007\/s12630-020-01903-1","journal-title":"Canadian Journal of Anesthesia"},{"issue":"3","key":"4170_CR89","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/pm\/pnaa396","volume":"22","author":"P Lucas","year":"2021","unstructured":"Lucas, P., Boyd, S., Milloy, M. J., & Walsh, Z. (2021). Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: Results of a large prospective study. Pain Medicine, 22(3), 727\u2013739. https:\/\/doi.org\/10.1093\/pm\/pnaa396","journal-title":"Pain Medicine (Malden, Mass.)"},{"key":"4170_CR90","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101010","author":"G Gulbransen","year":"2020","unstructured":"Gulbransen, G., Xu, W., & Arroll, B. (2020). Cannabidiol prescription in clinical practice: An audit on the first 400 patients in New Zealand. BJGP Open. https:\/\/doi.org\/10.3399\/bjgpopen20X101010","journal-title":"BJGP Open"},{"key":"4170_CR91","doi-asserted-by":"publisher","unstructured":"Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M. T., Smith, R. T., & Lukas, S. E. (2016). Splendor in the grass? A pilot study assessing the impact of medical marijuana on executive function. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2016.00355","DOI":"10.3389\/fphar.2016.00355"},{"key":"4170_CR92","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. (2022). Health-related quality of life. https:\/\/archive.cdc.gov\/www_cdc_gov\/hrqol\/index.htm. Accessed Aug 2025."},{"issue":"10","key":"4170_CR93","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of eq-5d (eq-5d-5l). Quality of Life Research, 20(10), 1727\u20131736. https:\/\/doi.org\/10.1007\/s11136-011-9903-x","journal-title":"Quality of Life Research"},{"issue":"5","key":"4170_CR94","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/07853890109002089","volume":"33","author":"RD Hays","year":"2001","unstructured":"Hays, R. D., & Morales, L. S. (2001). The rand-36 measure of health-related quality of life. Annals of Medicine, 33(5), 350\u2013357. https:\/\/doi.org\/10.3109\/07853890109002089","journal-title":"Annals of Medicine"},{"issue":"3","key":"4170_CR95","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/bf02260859","volume":"4","author":"BG Vickrey","year":"1995","unstructured":"Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4(3), 187\u2013206. https:\/\/doi.org\/10.1007\/bf02260859","journal-title":"Quality of Life Research"},{"issue":"11","key":"4170_CR96","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1528-1157.1995.tb00467.x","volume":"36","author":"O Devinsky","year":"1995","unstructured":"Devinsky, O., Vickrey, B. G., Cramer, J., Perrine, K., Hermann, B., Meador, K., & Hays, R. D. (1995). Development of the quality of life in epilepsy inventory. Epilepsia, 36(11), 1089\u20131104. https:\/\/doi.org\/10.1111\/j.1528-1157.1995.tb00467.x","journal-title":"Epilepsia"},{"issue":"11","key":"4170_CR97","doi-asserted-by":"publisher","first-page":"e0272241","DOI":"10.1371\/journal.pone.0272241","volume":"17","author":"AW Vickery","year":"2022","unstructured":"Vickery, A. W., Roth, S., Ernenwein, T., Kennedy, J., & Washer, P. (2022). A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years. Plos One, 17(11), e0272241. https:\/\/doi.org\/10.1371\/journal.pone.0272241","journal-title":"Plos One"},{"issue":"10","key":"4170_CR98","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s11136-018-1921-5","volume":"27","author":"R Mercieca-Bebber","year":"2018","unstructured":"Mercieca-Bebber, R., Williams, D., Tait, M. A., Roydhouse, J., Busija, L., Sundaram, C. S., Wilson, M., Langford, A., Rutherford, C., Roberts, N., King, M., Vodicka, E., & Devine, B. (2018). Trials with patient-reported outcomes registered on the Australian new Zealand clinical trials registry (anzctr). Quality of Life Research, 27(10), 2581\u20132591. https:\/\/doi.org\/10.1007\/s11136-018-1921-5","journal-title":"Quality of Life Research"},{"key":"4170_CR99","unstructured":"European Medicines Agency. (2016). Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: The use of patient-reported outcome (pro) measures in oncology studies. European Medicines Agency London."},{"key":"4170_CR100","unstructured":"NHS Digital. (2025). Patient reported outcome measures (proms). https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/patient-reported-outcome-measures-proms. Accessed 3 Sep 2025."},{"issue":"14","key":"4170_CR101","doi-asserted-by":"publisher","first-page":"E694","DOI":"10.1503\/cmaj.091414","volume":"182","author":"MA Ware","year":"2010","unstructured":"Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., Gamsa, A., Bennett, G. J., & Collet, J. P. (2010). Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. CMAJ, 182(14), E694\u2013E701. https:\/\/doi.org\/10.1503\/cmaj.091414","journal-title":"Cmaj"},{"issue":"5\u20136","key":"4170_CR102","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000357427","volume":"71","author":"P Flachenecker","year":"2014","unstructured":"Flachenecker, P., Henze, T., & Zettl, U. K. (2014). Nabiximols (thc\/cbd oromucosal spray, sativex?) in clinical practice - results of a multicenter, non-interventional study (move 2) in patients with multiple sclerosis spasticity. European Neurology, 71(5\u20136), 271\u2013279. https:\/\/doi.org\/10.1159\/000357427","journal-title":"European Neurology"},{"issue":"1","key":"4170_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/ebmed-2017-110883","volume":"23","author":"D Nunan","year":"2018","unstructured":"Nunan, D., Aronson, J., & Bankhead, C. (2018). Catalogue of bias: Attrition bias. BMJ Evidence-Based Medicine, 23(1), 21\u201322. https:\/\/doi.org\/10.1136\/ebmed-2017-110883","journal-title":"BMJ Evidence-Based Medicine"},{"key":"4170_CR104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/ppa.s8135","volume":"4","author":"H Liu-Seifert","year":"2010","unstructured":"Liu-Seifert, H., Zhang, S., D\u2019Souza, D., & Skljarevski, V. (2010). A closer look at the baseline-observation-carried-forward (bocf). Patient Preference and Adherence, 4, 11\u201316. https:\/\/doi.org\/10.2147\/ppa.s8135","journal-title":"Patient Preference and Adherence"},{"issue":"4","key":"4170_CR105","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1017\/s2045796016000809","volume":"26","author":"P Cuijpers","year":"2017","unstructured":"Cuijpers, P., Weitz, E., Cristea, I. A., & Twisk, J. (2017). Pre-post effect sizes should be avoided in meta-analyses. Epidemiology and Psychiatric Sciences, 26(4), 364\u2013368. https:\/\/doi.org\/10.1017\/s2045796016000809","journal-title":"Epidemiology and Psychiatric Sciences"}],"updated-by":[{"DOI":"10.1007\/s11136-026-04216-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000}}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04170-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:07:54Z","timestamp":1775826474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04170-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04170-7","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Figure 5 and Supplementary information file (MOESM 6) areupdated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11136-026-04216-w","URL":"https:\/\/doi.org\/10.1007\/s11136-026-04216-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Financial interests: Louise Acret, Daniel SJ Costa, Rachel Campbell, and Kate White declare they have no financial interests. Margaret-Ann Tait and Claudia Rutherford have previously received research support from Little Green Pharma Ltd. Non-financial interests: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"56"}}